VIDROP ORAL DROPS 15ML

Benefits & Uses

Primary Benefit

Supports bone health, calcium absorption, and immune function through Vitamin D3 supplementation.

Health Claims

Supports normal bone and teeth development; contributes to normal calcium and phosphorus absorption; supports immune system function; reduces risk of rickets in infants and children; supports normal muscle function.

Common Deficiency Symptoms

Rickets in children, bone pain, muscle weakness, delayed growth, frequent infections, fatigue, irritability, dental problems.

Target Population

Infants and children at risk of vitamin D deficiency, exclusively breastfed infants, children with limited sun exposure, dark-skinned children, children in northern latitudes or those with malabsorption conditions.

Scientific Evidence Level

Strong

Usage & Dosage

Suggested Use

Administer orally as directed by a physician; drops can be placed directly in the mouth or mixed with food or milk.

Serving Size

Physician-directed number of drops; concentration is 2800 IU/ml

Best Time to Take

With meals

Recommended Daily Intake

Infants (0-12 months): 400 IU/day (10mcg). Children (1+ years) & Adults (to 70 years): 600 IU/day (15mcg). Adults (>70 years): 800 IU/day (20mcg).

Upper Tolerable Limit

Infants (0-6 months): 1000 IU/day; Infants (7-12 months): 1500 IU/day; Children (1-3 years): 2500 IU/day; Children (4-8 years): 3000 IU/day; Children (9+ years) and adults: 4000 IU/day.

Absorption Enhancers

Administer with a fat-containing meal to maximize absorption; magnesium supports conversion to the active form; vitamin K2 enhances calcium utilization.

Absorption Inhibitors

Orlistat (fat absorption blocker) reduces vitamin D absorption; cholestyramine and colestipol reduce absorption; high-dose calcium supplements may interfere with metabolism.

Side Effects

Possible Side Effects

At recommended doses: generally well-tolerated; excessive doses may cause hypercalcemia, nausea, vomiting, constipation, polyuria, polydipsia, weakness, and in severe cases nephrocalcinosis.

Toxicity Risk

Medium

Upper Tolerable Limit

Infants (0-6 months): 1000 IU/day; Infants (7-12 months): 1500 IU/day; Children (1-3 years): 2500 IU/day; Children (4-8 years): 3000 IU/day; Children (9+ years) and adults: 4000 IU/day.

Safety & Warnings

Contraindications

Contraindicated in hypercalcemia, hypervitaminosis D, and hypersensitivity to colecalciferol (cholecalciferol) or any excipient. Conditions such as hypercalciuria, nephrolithiasis, severe renal impairment, and granulomatous diseases (e.g., sarcoidosis) are precautions requiring avoidance of excessive dosing and monitoring rather than absolute contraindications.

Pregnancy Safety

Consult Doctor

Breastfeeding Safety

Consult Doctor

Children Suitability

Suitable from birth (neonates and infants); dose must be determined by a physician based on age and weight.

Interactions

Medication Interactions

Orlistat reduces absorption; thiazide diuretics increase hypercalcemia risk; corticosteroids reduce vitamin D metabolism; anticonvulsants (phenytoin, phenobarbital) accelerate vitamin D catabolism; digoxin toxicity risk increases with hypercalcemia induced by excess vitamin D.

Supplement Interactions

High-dose calcium supplements combined with excess vitamin D may increase hypercalcemia risk; high-dose vitamin A may antagonize vitamin D activity; avoid concurrent use of other high-dose vitamin D supplements without medical advice.

Special Populations

Target Population

Infants and children at risk of vitamin D deficiency, exclusively breastfed infants, children with limited sun exposure, dark-skinned children, children in northern latitudes or those with malabsorption conditions.

Children Suitability

Suitable from birth (neonates and infants); dose must be determined by a physician based on age and weight.

Pregnancy Safety

Consult Doctor

Breastfeeding Safety

Consult Doctor

Storage & Patient Advice

SFDA Storage Conditions

store below 25°c

Patient Counseling

VIDROP oral drops contain cholecalciferol (vitamin D3) 2800 IU/mL for oral use. Administer exactly as directed; measure the dose carefully with the supplied dropper and do not exceed the recommended dose (vitamin D is fat‑soluble and excess can accumulate). It may be taken with or without food; taking with a meal containing some fat can improve absorption. Avoid using other vitamin D-containing products and high‑dose calcium supplements unless advised by a clinician. Seek medical advice if symptoms of hypercalcemia/vitamin D toxicity occur (e.g., nausea/vomiting, constipation, poor appetite, excessive thirst, frequent urination, weakness, confusion). Breastfed infants often require vitamin D supplementation per pediatric guidance. Store below 25°C.

Science & Evidence

Bioavailability Form

Cholecalciferol (Vitamin D3) - the most bioavailable form of vitamin D, significantly more effective than ergocalciferol (D2) at raising and sustaining serum 25-hydroxyvitamin D levels.

Water or Fat Soluble

Fat-soluble

Scientific Evidence Level

Strong

Food Sources

Fatty fish (salmon, mackerel, sardines), cod liver oil, egg yolks, fortified milk and dairy products, fortified cereals, UV-exposed mushrooms.

Product Information

Supplement Type

Vitamin

Allergen Info

Cholecalciferol is derived from lanolin (sheep wool - animal source); may contain excipients derived from animal sources; consult product label for full excipient list; manufactured by Medical Union Pharmaceuticals, Egypt.

Suitable for Vegans

No, derived from lanolin

Age Range

0-6 months

Flavor

Unflavored